I am a physician-scientist and hepatologist at the University of Southern California with a research interest in Drug-Induced Liver Injury and Autoimmune Liver Diseases. I study mechanisms of liver injury and hepatotoxicity with a particular focus on cell death pathways using basic, animal model, and translational approaches. My lab currently focuses on Immune-mediated Liver Injury from Checkpoint Inhibitors and the complex interplay if signaling mechanisms leading to hepatotoxicity in immunotherapy.

Dr. Jesudian is a Transplant Hepatologist whose research focuses on improving outcomes in patients with cirrhosis and complications of portal hypertension through quality improvement. He is a Professor of Clinical Medicine, Director of Liver Quality and Inpatient Liver Services at NewYork-Presbyterian Hospital/Weill Cornell Medicine. He serves as Chair-Elect of the Practice Metrics Committee.

Indira Bhavsar-Burke, M.D., M.H.P.E., is an Assistant Professor in the Division of Digestive and Liver Diseases at UT Southwestern Medical Center, where she serves as Associate Program Director for the Internal Medicine Residency and Gastroenterology Fellowship programs. With interests in ACLF and medical education, her academic work focuses largely on faculty development, competency-based education, and coaching in graduate medical education. She also serves on the ABIM Gastroenterology Subspecialty Board.

Elliot Tapper, FAASLD is Professor at the University of Michigan

Dr. Christina Lindenmeyer is an Associate Professor of Medicine and Transplant Hepatologist in the Department of Gastroenterology, Hepatology and Nutrition. After graduating from Jefferson Medical College in Philadelphia, Dr. Lindenmeyer completed her residency in Internal Medicine at Thomas Jefferson University Hospital. She then completed fellowships in Gastroenterology and Transplant Hepatology at the Cleveland Clinic in Cleveland, Ohio.​

Dr. Khan is a current gastroenterology fellow at the Mayo Clinic in Rochester with a passion for liver disease. Her academic interests include hepatobiliary neoplasia, medical education and healthcare disparities.

Assistant Professor in Transplant Hepatology at The University of Michigan and Associate Program Director for the Michigan GI fellowship. Prior lead of the AASLD Liver Fellow Network.

Naim Alkhouri, MD, FAASLD, DABOM is the Chief Medical Officer at Summit Clinical Research and the Director of Research at the Clinical Research Institute of Ohio (CRIOH) in Cleveland, OH. Dr. Alkhouri is a key opinion leader in the field of MASH therapeutics and an advisor/ consultant to many pharmaceutical and biomarker development companies. He is Principal Investigator on several multicenter global MASH trials and a member of the AASLD MASLD Special Interest Group (MASLD SIG).

Sujan Ravi, MD, is a transplant hepatologist and Associate Professor of Medicine at the University of Alabama at Birmingham (UAB). His clinical and academic interests focus on improving care for patients with chronic liver disease. He serves as an Associate Principal in UAB's Clinical Transformation Office, where he leads multidisciplinary efforts to improve healthcare delivery, clinical operations, access, and quality across complex health systems. Dr.